When tax-exempt or non-U.S. taxpayers invest in U.S. businesses, unwanted and unintended U.S. tax obligations can follow without careful planning. Blocker corporations have become a common strategy employed...
Obtaining a Phase I environmental site assessment (ESA) is essential to conducting environmental due diligence for commercial real estate transactions. The goal of a Phase I ESA is to evaluate readily...
Artificial intelligence (AI) tools and resources are inundating the news, social media, professional seminars, and inboxes. AI is part of every conversation across industries and professional services...
Do you need guidance in defending against claims brought under the recently overhauled California's Private Attorneys General Act (PAGA)? Read Private Attorneys General Act in California: Defending...
Confidently present your case in chief to the Trademark Trial and Appeal Board (TTAB) with this opening trial brief that an opposer/petitioner (plaintiff) may use in an opposition or cancellation proceeding...
Earlier this month, the federal government deemed monkeypox a national public health emergency, and it continues to make efforts to stretch its vaccine supply to combat the virus. Meanwhile, daily cases of COVID-19 remain above 100,000. In June, the Centers for Disease Control and Prevention (CDC) expanded eligibility for COVID-19 vaccinations to the country’s approximately 20 million children between six months and five years of age. Accordingly, now is the time to get up to speed on pharmacist-provided immunization and vaccination requirements. Rely on this Practical Guidance 50-state survey to identify relevant state laws and understand state requirements regarding pharmacist administration, immunization registries, and administration to minors.
READ NOW »
Related Content
Legal Developments
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+